Digital Pathology Today™ is your podcast all about the world of digital pathology.  Each week, we talk with industry leaders, key academics, top pathologists and more to discover the past, present and future of digital pathology.  Join us every week for another look at Digital Pathology Today™.

Hosted by pathologist Dr. Joseph Anderson.

Current Episode

Season 3, Episode 9

"It Has to be Led by Somebody"  

This episode of Digital Pathology Today™ our guest is  Ken Bloom, MD, Head of Pathology at Nucleai.     

We examine the beginnings of telepathology, which led to what we now know as digital pathology in the 1980s. We trace the journey to now, focusing on seminal events in the industry, such as computational pathology, computer-assisted image analysis, the development of CPT codes, the importance of the TCPC split, particularly in the reference lab setting,

We also discuss the democratization of immunohistochemistry in connection with digital pathology and touch on recent developments in the assessment of  tumor heterogeneity, AI algorithms, and spatial analysis. Additionally, we explore the role of pathologists in the era of precision medicine, and the potential for integration of pathology with radiology.

Dr. Kenneth J. Bloom is currently the head of pathology at Nucleai. He has more than 35 years of clinical experience in pathology, oncology, telemedicine, and bioinformatics. Dr. Bloom previously served as the Chief Medical Officer at Invicro and Ambry Genetics. He was also President and Head of Oncology and Immunotherapy for Human Longevity Inc.

He played an instrumental role in designing the business strategy that grew Clarient from a startup with no revenue to its acquisition by GE. He oversaw the development of hundreds of laboratory-developed tests, including those using IHC, ISH, Flow Cytometry, and Molecular methods.

 Dr. Bloom spent 15 years at Rush Medical College, where he held various titles, including Director of Laboratory Operations and Chief Information Officer of the Rush Cancer Institute

All opinions and views expressed on Digital Pathology Today™ are those of the individual expressing them.  No guests have paid nor been paid for their appearance on Digital Pathology Today™.   Digital Pathology Today™ does not endorse any specific products or technologies mentioned on the show.